GlassScriptPhysician profile
Grace A Gibbs
NPI 1306866074
$2,835.63
in general payments reported to CMS, 2019-2025
25 companies · $74.70 in 2025
The $74.70 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,762 · 2020: $377 · 2021: $622 · 2025: $74.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.85 · Education: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.85 |
| Education | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $400.74 | 2019 | |
| Abbvie INC. | $355.08 | 2019-2021 | |
| Hologic Sales and Service, LLC | $277.97 | 2019-2021 | |
| Coopersurgical, INC. | $258.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $185.61 | 2019-2021 | |
| Ethicon US, LLC | $173.28 | 2019-2020 | |
| Allergan, INC. | $164.80 | 2019-2020 | |
| Pfizer INC. | $143.50 | 2019-2021 | |
| Therapeuticsmd, INC. | $129.42 | 2019-2020 | |
| Terumo Medical Corporation | $90.15 | 2019 | |
| Astellas Pharma US INC | $86.88 | 2019-2020 | |
| Avion Pharmaceuticals | $86.63 | 2019-2021 | |
| Exeltis, USA INC. | $75.70 | 2021 | |
| Mylan Pharmaceuticals INC. | $62.96 | 2021 | |
| Lupin INC. | $61.28 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $55.98 | 2025 | Vivitrol |
| Pacira Pharmaceuticals Incorporated | $45.52 | 2021 | |
| Axonics, INC. | $38.10 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $33.71 | 2019 | |
| Mayne Pharma Commercial LLC | $29.55 | 2021 | |
| Myovant Sciences INC. | $20.23 | 2021 | |
| Gilead Sciences, INC. | $18.72 | 2025 | |
| Duchesnay USA Incorporated | $16.95 | 2019 | |
| Agile Therapeutics, INC. | $13.04 | 2021 | |
| Evofem Biosciences, INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Gibbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.